» Articles » PMID: 30894138

LncRNA PVT1 Regulates Atrial Fibrosis Via MiR-128-3p-SP1-TGF-β1-Smad Axis in Atrial Fibrillation

Overview
Journal Mol Med
Publisher Biomed Central
Date 2019 Mar 22
PMID 30894138
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Long non-coding RNAs (lncRNA) plasmacytoma variant translocation 1 (PVT1) has been shown to be associated with liver fibrosis. Nevertheless, the role of PVT1 in atrial fibrosis remains undefined. This study aims to elucidate the pathophysiological role of lncRNA PVT1 in the regulation of atrial fibrosis and to explore the underlying mechanism.

Methods: Expression of PVT1, miR-128-sp, and Sp1 were examined in human atrial muscle tissues and angiotensin-II (Ang-II)-induced human atrial fibroblasts. Furthermore, the role of PVT1 in regulating atrial fibrosis in Ang-II-treated human atrial fibroblasts and Ang-II-induced atrial fibrosis in mice was investigated. Moreover, the interaction among PVT1, miR-128-3p, and Sp1 were examined using bioinformatics, expression correlation analysis, gain- or loss-of-function assays, RIP assays, and luciferase reporter assays. The involvement of transforming growth factor beta 1 (TGF-β1)/Smad pathway in this process was also explored.

Results: PVT1 was increased in atrial muscle tissues from AF patients and positively with collagen I and collagen III. In vitro assay revealed that PVT1 overexpression facilitated the Ang-II-induced atrial fibroblasts proliferation, collagen production, and TGF-β1/Smad signaling activation, whereas PVT1 knockdown caused the opposite effect. In vivo assay further confirmed that PVT1 knockdown attenuated the Ang-II-induced mouse atrial fibrosis. Mechanically, PVT1 acted as a sponge for miR-128-3p to facilitate Sp1 expression, thereby activating the TGF-β1/Smad signaling pathway.

Conclusion: LncRNA PVT1 promotes atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.

Citing Articles

Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial Fibrillation.

Zheng E, Warchol I, Mejza M, Mozdzan M, Strzeminska M, Bajer A J Clin Med. 2025; 14(3).

PMID: 39941553 PMC: 11818443. DOI: 10.3390/jcm14030882.


The role of long non-coding RNAs in cardiovascular diseases: A comprehensive review.

Xie X, Huang M, Ma S, Xin Q, Wang Y, Hu L Noncoding RNA Res. 2025; 11:158-187.

PMID: 39896344 PMC: 11783329. DOI: 10.1016/j.ncrna.2024.12.009.


Hydrogen decreases susceptibility to AngII-induced atrial fibrillation and atrial fibrosis via the NOX4/ROS/NLRP3 and TGF-β1/Smad2/3 signaling pathways.

Zhang B, Hou J, Liu J, He J, Gao Y, Li G PLoS One. 2025; 20(1):e0310852.

PMID: 39775356 PMC: 11709313. DOI: 10.1371/journal.pone.0310852.


CCRR regulate MYZAP-PKP2-Nav1.5 signaling pathway in atrial fibrillation following myocardial infarction.

Xuan L, Guo J, Luo H, Cui S, Sun F, Wang G iScience. 2024; 27(11):111102.

PMID: 39507261 PMC: 11539591. DOI: 10.1016/j.isci.2024.111102.


Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling.

Chia Z, Kumarapperuma H, Zhang R, Little P, Kamato D Acta Pharmacol Sin. 2024; .

PMID: 39506064 DOI: 10.1038/s41401-024-01413-6.


References
1.
Dobaczewski M, Chen W, Frangogiannis N . Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 2010; 51(4):600-6. PMC: 3072437. DOI: 10.1016/j.yjmcc.2010.10.033. View

2.
Choi E, Chang P, Lee Y, Lin S, Zhu W, Maruyama M . Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-β1. Circ J. 2012; 76(6):1354-62. PMC: 3593311. DOI: 10.1253/circj.cj-11-1301. View

3.
Lee K, Chae J, Shim J . Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma. J Biomed Sci. 2012; 19:60. PMC: 3431247. DOI: 10.1186/1423-0127-19-60. View

4.
Zhang P, Wang W, Wang X, Wang X, Song Y, Zhang J . Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease. Int J Cardiol. 2013; 168(4):3200-7. DOI: 10.1016/j.ijcard.2013.04.113. View

5.
Yeh Y, Kuo C, Chang G, Qi X, Nattel S, Chen W . Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β. Circ Arrhythm Electrophysiol. 2013; 6(4):790-8. DOI: 10.1161/CIRCEP.113.000338. View